Abiopharma

Share Consolidation

(30% Negative) CORE MOLDING TECHNOLOGIES INC (CMT) Reports Q1 2026 Financial Results

Rights Announcement Withdrawn

Share Consolidation

(30% Negative) ADC THERAPEUTICS SA (ADCT) Reports Q1 2026 Financial Results

(10% Negative) SAB BIOTHERAPEUTICS, INC. (SABSW) Announces Delay in biologic Trials for C-peptide levels at Day 120 compared to baseline Due to Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(10% Negative) TENAX THERAPEUTICS, INC. (TENX) Announces Delay in period Trials for LEVEL has closed Due to Geopolitical Situation, Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations

(99% Neutral) HARVARD BIOSCIENCE, INC. (HBIO) Announces New Board Appointment

(30% Negative) CULLINAN THERAPEUTICS, INC. (CGEM) Reports Q1 2026 Financial Results

(30% Negative) ESPERION THERAPEUTICS, INC. (ESPR) Reports Q1 2026 Financial Results